Stage one results from PLL Therapeutics’ first-in-human, multi-stage phase I/II trial show favorable safety and tolerability of PLL001 in 12 ALS patients Villenave-d’Ornon (near Bordeaux), France, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results